Results 1 to 10 of about 11,681 (175)

Acute parvovirus B19 infection associated with multi-organ involvement in an immunocompetent adult [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Introduction: Human parvovirus B19 is a highly prevalent single-stranded deoxyribonucleic acid virus that infects a large proportion of the global population.
Akshaye Gopaul   +2 more
doaj   +2 more sources

Parvovirus B19 Rebound. [PDF]

open access: yesJ Med Virol
ABSTRACTHuman parvovirus B19 (B19V) is responsible for a wide clinical spectrum ranging from asymptomatic infection, through mild disease, up to life‐threatening one. Outbreaks are registered every 3–4 years, and a recent international alert for a new outbreak has been released.
Ranno S   +14 more
europepmc   +3 more sources

Severe parvovirus B19 infection in patients with sickle cell disease hospitalized in intensive care units [PDF]

open access: yesBlood Advances
: Parvovirus B19 infection can lead to severe complications in patients with chronic hemolysis. The aim of this study was to describe severe parvovirus B19 infections in adult patients with sickle cell disease (SCD).
Ségolène Gendreau   +18 more
doaj   +2 more sources

A case of parvovirus B19 infection mimicking mumps virus infection in a healthy adult [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Introduction: Human parvovirus B19 infection classically manifests as erythema infectiosum in children, but in adults the clinical spectrum is diverse and often atypical.
Hiraku Sedogawa   +5 more
doaj   +2 more sources

Detection of Parvovirus B19 DNA in pregnant Sudanese women attending The Military hospital using Nested PCR technique

open access: yesمجله كليه طب الكندي, 2022
Background: Parvovirus B19 is a human pathogenic virus associated with a wide range of clinical conditions. During pregnancy congenital infection with parvovirus B19 can be associated with poor outcome, including miscarriage, fetal anemia and non-immune
Tagwa Hafiz Abdelkabeer   +4 more
doaj   +1 more source

Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis

open access: yesUrology Annals, 2020
Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear.
Charat Thongprayoon   +13 more
doaj   +1 more source

Human Parvovirus B19 [PDF]

open access: yesClinical Microbiology Reviews, 2002
SUMMARYParvovirus B19(B19) was discovered in 1974 and is the only member of the familyParvoviridaeknown to be pathogenic in humans. Despite the inability to propagate the virus in cell cultures, much has been learned about the pathophysiology of this virus, including the identification of the cellular receptor (P antigen), and the control of the virus ...
Erik D, Heegaard, Kevin E, Brown
openaire   +2 more sources

Investigation into Parvovirus B19 Antibodies in Serum Samples Sent with Pre-diagnosis of Arthritis-Arthralgia

open access: yesThe Anatolian Journal of Family Medicine, 2020
INTRODUCTION[|]Parvovirus B19 belonging to the Erythrovirus genus is a single-stranded DNA virus in the family Parvoviridae. The present study aims to determine parvovirus B19 seropositivity in serum samples sent with pre-diagnosis of arthritis ...
Hilal Türkmen Albayrak   +3 more
doaj   +1 more source

Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient

open access: yesFrontiers in Immunology, 2023
Immunosuppressed patients can contract parvovirus B19, and some may experience hemophagocytic lymphohistiocytosis (HLH). Herein, we describe the first report of hemophagocytic lymphohistiocytosis in a heart-lung transplant patient with concomitant ...
Xuewu Zhang   +11 more
doaj   +1 more source

The association between Parvovirus B19 infection and persistent anaemia in renal transplant recipients

open access: yesJournal of Clinical Virology Plus, 2022
Background: The immunosuppressive drug therapy makes post-transplant recipients are at risk of developing both primary viral diseases and reactivation of persistent viruses.
K.D.S.T. Abeywardana, S.N. Janage
doaj   +1 more source

Home - About - Disclaimer - Privacy